| GRP | Gastrin-Releasing Peptide |
|---|---|
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
| BG | basal ganglion; basic gastrin; Bender Gestalt [test]; beta-galactosidase; beta-glucuronidase; bicolo... |
| FGL | fasting gastrin level |
| GRF | gastrin-releasing factor; genetically related macrophage factor; gonadotropin-releasing factor; grow... |
| abnormal placental size | <radiology> TOO BIG (greater than5cm in sections obtained at right angles to the long axis), maternal disease, diabetic mothers (= villous oedema), intrauterine infections, anaemic mothers (= normal histology), foetal disease, erythroblatosis foetalis (= villous oedema and hyperplasia), umbilical vein obstruction, foetal high output failure, large chorioangioma, sacrococcygeal teratoma, arteriovenous fistula too small, preeclampsia (associated with placental infarcts in 33-60%) (12 Dec 1998) |
|---|---|
| reflex, abnormal | Abnormal, involuntary response to a stimulus which includes hyperreflexia, hyporeflexia, and areflexia. (12 Dec 1998) |
| cellular immunodeficiency with abnormal immunoglobulin synthesis | An ill-defined group of sporadic disorders of unknown cause, occurring in both males and females and associated with recurrent bacterial, fungal, protozoal, and viral infections; there is thymic hypoplasia with depressed cellular (T-lymphocyte) immunity combined with defective humoral (B-lymphocyte) immunity, although immunoglobulin levels may be normal. Synonym: Nezelof syndrome, Nezelof type of thymic alymphoplasia. (05 Mar 2000) |
| haemoglobins, abnormal | Haemoglobins altered in their genetically determined molecular structure, resulting in a characteristic complex of vlinival and laboratory abnormalities. The specific features of the abnormal haemoglobins are related to variation of the composite globin polypeptide chains. (12 Dec 1998) |
| pupillary functions, abnormal | Conditions in which the pupil does not react normally to dilation and constriction. Signs of pupillary abnormalities originate from the pupil's shape, position, and response to stimulation. (12 Dec 1998) |
| fibrinogens, abnormal | Fibrinogens which have a functional defect as the result of one or more amino acid substitutions in the amino acid sequence of normal fibrinogen. Abnormalities of the fibrinogen molecule may impair any of the major steps involved in the conversion of fibrinogen into stabilised fibrin, such as cleavage of the fibrinopeptides by thrombin, polymerization and cross-linking of fibrin. The resulting dysfibrinogenaemias can be clinically silent or can be associated with bleeding, thrombosis or defective wound healing. (12 Dec 1998) |